Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT
Monopar Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 39.5B | 39.71M | 45.82M | 6.02M | 6.12M | 7.81M | 7.27M | 5.52M | 7.21M | 5.73M | 8.19M | 14.32M | 16.46M | 17.82M | 20.3M | 22.34M | 24.29M | 25.72M |
Short-Term Investments | n/a | 14.84M | 14.4M | n/a | 998.84K | 985.73K | n/a | 2.98M | 2.98M | 5.95M | 4.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | 0.00 | 0.00 | n/a | -0.00 | n/a | n/a | 68.86K | 68.86K | 68.86K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 14.25B | 523.56K | 78.87K | 49.57K | 61.02K | 118.99K | n/a | 73.19K | 109.87K | 106.82K | 45.98K | 55.7K | 189.18K | 193.63K | 217.75K | 106.8K | 95.56K | 114.57K |
Total Current Assets | 53.75B | 55.08M | 60.29M | 6.07M | 7.18M | 8.91M | 7.33M | 8.57M | 10.3M | 11.78M | 13.17M | 14.37M | 16.65M | 18.01M | 20.52M | 22.45M | 24.39M | 25.84M |
Property-Plant & Equipment | 118.17M | 9.1K | n/a | n/a | n/a | n/a | 12.65K | 25.09K | 37.33K | 49.38K | 61.23K | 72.89K | 84.36K | 53.69K | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 118.17M | 9.1K | n/a | n/a | n/a | n/a | 12.65K | 25.09K | 37.33K | 49.38K | 61.23K | 72.89K | 84.36K | 53.69K | n/a | 68.86K | 68.86K | 68.86K |
Total Assets | 53.87B | 55.09M | 60.29M | 6.07M | 7.18M | 8.91M | 7.35M | 8.59M | 10.34M | 11.83M | 13.23M | 14.45M | 16.74M | 18.07M | 20.52M | 22.52M | 24.46M | 25.91M |
Account Payables | n/a | 1.49M | 2.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.13M | 1.91M | 2.19M | 1.07M | 1.58M | 1.24M | 1.1M | 806.27K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.58B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.58B | 1.49M | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.13M | 1.91M | 2.19M | 1.07M | 1.58M | 1.24M | 1.1M | 806.27K |
Long-Term Debt | 80.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 80.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.89M | 8.41K | 20.85K | 33.09K | 25.34K | n/a | n/a | n/a | n/a |
Total Liabilities | 1.66B | 1.49M | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M | 1.98M | 2.5M | 2.89M | 3.14M | 1.94M | 2.22M | 1.1M | 1.58M | 1.24M | 1.1M | 806.27K |
Total Debt | 80.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.41K | 20.85K | 33.09K | 25.34K | n/a | n/a | n/a | n/a |
Common Stock | 6.13M | 6.12K | 6.1K | 3.52M | 17.6K | 17.48K | 14.9K | 14.2K | 13.9K | 13.22K | 12.95K | 12.86K | 12.7K | 12.62K | 12.6K | 12.59K | 12.58K | 12.57K |
Retained Earnings | -80.87B | -78.42M | -75.79M | -64.87M | -63.56M | -61.85M | -60.21M | -58.39M | -56.44M | -54.24M | -51.8M | -48.91M | -46.51M | -43.75M | -41.29M | -38.61M | -36.15M | -34.07M |
Comprehensive Income | 77.58M | -21.78K | 35.99K | -10.99K | 8.26K | 4.23K | -14.13K | 3.95K | 7.22K | 31.79K | 8.94K | 42.98K | 17.47K | -3.74K | -3.16K | -5.15K | -5.16K | -5.1K |
Shareholders Equity | 52.2B | 53.59M | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M | 6.61M | 7.84M | 8.94M | 10.09M | 12.51M | 14.52M | 16.97M | 18.94M | 21.28M | 23.35M | 25.1M |
Total Investments | n/a | 14.84M | 14.4M | 6.01B | 998.84K | 985.73K | n/a | 2.98M | 2.98M | 5.95M | 4.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |